 | • レポートコード：MRC2Q12-19079 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、グラミシジンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 グラミシジンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 グラミシジンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 グラミシジンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのグラミシジンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のグラミシジンの売上および2028年までの予測に焦点を当てています。 グラミシジンのグローバル主要企業には、Sanofi、Teva、AbbVie、Amring Pharma、Bausch and Lomb、Bimeda、Bristol Myers Squibb、Dow Pharma、ERFA Canada、Euro Pharm、IPharma、Johnson and Johnson、Odan Laboratories、Pfizer、Sifiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 グラミシジン市場は、タイプとアプリケーションによって区分されます。世界のグラミシジン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 液体、軟膏 【アプリケーション別セグメント】 抗生物質、のど痛み治療、創傷感染症、点眼薬、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - グラミシジン製品概要 - タイプ別市場（液体、軟膏） - アプリケーション別市場（抗生物質、のど痛み治療、創傷感染症、点眼薬、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のグラミシジン販売量予測2017-2028 - 世界のグラミシジン売上予測2017-2028 - グラミシジンの地域別販売量 - グラミシジンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別グラミシジン販売量 - 主要メーカー別グラミシジン売上 - 主要メーカー別グラミシジン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（液体、軟膏） - グラミシジンのタイプ別販売量 - グラミシジンのタイプ別売上 - グラミシジンのタイプ別価格 ・アプリケーション別市場規模（抗生物質、のど痛み治療、創傷感染症、点眼薬、その他） - グラミシジンのアプリケーション別販売量 - グラミシジンのアプリケーション別売上 - グラミシジンのアプリケーション別価格 ・北米市場 - 北米のグラミシジン市場規模（タイプ別、アプリケーション別） - 主要国別のグラミシジン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのグラミシジン市場規模（タイプ別、アプリケーション別） - 主要国別のグラミシジン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のグラミシジン市場規模（タイプ別、アプリケーション別） - 主要国別のグラミシジン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のグラミシジン市場規模（タイプ別、アプリケーション別） - 主要国別のグラミシジン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのグラミシジン市場規模（タイプ別、アプリケーション別） - 主要国別のグラミシジン市場規模（トルコ、サウジアラビア） ・企業情報 Sanofi、Teva、AbbVie、Amring Pharma、Bausch and Lomb、Bimeda、Bristol Myers Squibb、Dow Pharma、ERFA Canada、Euro Pharm、IPharma、Johnson and Johnson、Odan Laboratories、Pfizer、Sifi ・産業チェーン及び販売チャネル分析 - グラミシジンの産業チェーン分析 - グラミシジンの原材料 - グラミシジンの生産プロセス - グラミシジンの販売及びマーケティング - グラミシジンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - グラミシジンの産業動向 - グラミシジンのマーケットドライバー - グラミシジンの課題 - グラミシジンの阻害要因 ・主な調査結果 |
Gramicidin, also called gramicidin D, is a mix of ionophoric antibiotics, gramicidin A, B and C, which make up about 80%, 5%, and 15% of the mix, respectively
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Gramicidin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Gramicidin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Gramicidin is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Gramicidin include Sanofi, Teva, AbbVie, Amring Pharma, Bausch and Lomb, Bimeda, Bristol Myers Squibb, Dow Pharma and ERFA Canada, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Gramicidin manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Gramicidin market. Further, it explains the major drivers and regional dynamics of the global Gramicidin market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sanofi
Teva
AbbVie
Amring Pharma
Bausch and Lomb
Bimeda
Bristol Myers Squibb
Dow Pharma
ERFA Canada
Euro Pharm
IPharma
Johnson and Johnson
Odan Laboratories
Pfizer
Sifi
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by dosage form and by application segments based on sales, price, and value for the period 2017-2028.
Gramicidin Segment by Dosage Form
Liquid
Ointment
Gramicidin Segment by Application
Antibiotic
Treatment of Sore Throat
Wound Infection
Eyedrop
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Gramicidin market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Gramicidin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Gramicidin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Gramicidin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gramicidin sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Gramicidin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Gramicidin sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi, Teva, AbbVie, Amring Pharma, Bausch and Lomb, Bimeda, Bristol Myers Squibb, Dow Pharma and ERFA Canada, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Gramicidin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Gramicidin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by dosage form, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by dosage form, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by dosage form, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by dosage form, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gramicidin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Gramicidin Product Introduction
1.2 Market by Dosage Form
1.2.1 Global Gramicidin Market Size Growth Rate by Dosage Form, 2017 VS 2021 VS 2028
1.2.2 Liquid
1.2.3 Ointment
1.3 Market by Application
1.3.1 Global Gramicidin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Antibiotic
1.3.3 Treatment of Sore Throat
1.3.4 Wound Infection
1.3.5 Eyedrop
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gramicidin Sales Estimates and Forecasts 2017-2028
2.2 Global Gramicidin Revenue Estimates and Forecasts 2017-2028
2.3 Global Gramicidin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Gramicidin Sales by Region
2.4.1 Global Gramicidin Sales by Region (2017-2022)
2.4.2 Global Sales Gramicidin by Region (2023-2028)
2.5 Global Gramicidin Revenue by Region
2.5.1 Global Gramicidin Revenue by Region (2017-2022)
2.5.2 Global Gramicidin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Gramicidin Sales by Manufacturers
3.1.1 Global Top Gramicidin Manufacturers by Sales (2017-2022)
3.1.2 Global Gramicidin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gramicidin in 2021
3.2 Global Gramicidin Revenue by Manufacturers
3.2.1 Global Gramicidin Revenue by Manufacturers (2017-2022)
3.2.2 Global Gramicidin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Gramicidin Revenue in 2021
3.3 Global Gramicidin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Gramicidin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Gramicidin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Dosage Form
4.1 Global Gramicidin Sales by Dosage Form
4.1.1 Global Gramicidin Historical Sales by Dosage Form (2017-2022)
4.1.2 Global Gramicidin Forecasted Sales by Dosage Form (2023-2028)
4.1.3 Global Gramicidin Sales Market Share by Dosage Form (2017-2028)
4.2 Global Gramicidin Revenue by Dosage Form
4.2.1 Global Gramicidin Historical Revenue by Dosage Form (2017-2022)
4.2.2 Global Gramicidin Forecasted Revenue by Dosage Form (2023-2028)
4.2.3 Global Gramicidin Revenue Market Share by Dosage Form (2017-2028)
4.3 Global Gramicidin Price by Dosage Form
4.3.1 Global Gramicidin Price by Dosage Form (2017-2022)
4.3.2 Global Gramicidin Price Forecast by Dosage Form (2023-2028)
5 Market Size by Application
5.1 Global Gramicidin Sales by Application
5.1.1 Global Gramicidin Historical Sales by Application (2017-2022)
5.1.2 Global Gramicidin Forecasted Sales by Application (2023-2028)
5.1.3 Global Gramicidin Sales Market Share by Application (2017-2028)
5.2 Global Gramicidin Revenue by Application
5.2.1 Global Gramicidin Historical Revenue by Application (2017-2022)
5.2.2 Global Gramicidin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Gramicidin Revenue Market Share by Application (2017-2028)
5.3 Global Gramicidin Price by Application
5.3.1 Global Gramicidin Price by Application (2017-2022)
5.3.2 Global Gramicidin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Gramicidin Market Size by Dosage Form
6.1.1 North America Gramicidin Sales by Dosage Form (2017-2028)
6.1.2 North America Gramicidin Revenue by Dosage Form (2017-2028)
6.2 North America Gramicidin Market Size by Application
6.2.1 North America Gramicidin Sales by Application (2017-2028)
6.2.2 North America Gramicidin Revenue by Application (2017-2028)
6.3 North America Gramicidin Market Size by Country
6.3.1 North America Gramicidin Sales by Country (2017-2028)
6.3.2 North America Gramicidin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Gramicidin Market Size by Dosage Form
7.1.1 Europe Gramicidin Sales by Dosage Form (2017-2028)
7.1.2 Europe Gramicidin Revenue by Dosage Form (2017-2028)
7.2 Europe Gramicidin Market Size by Application
7.2.1 Europe Gramicidin Sales by Application (2017-2028)
7.2.2 Europe Gramicidin Revenue by Application (2017-2028)
7.3 Europe Gramicidin Market Size by Country
7.3.1 Europe Gramicidin Sales by Country (2017-2028)
7.3.2 Europe Gramicidin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Gramicidin Market Size by Dosage Form
8.1.1 Asia Pacific Gramicidin Sales by Dosage Form (2017-2028)
8.1.2 Asia Pacific Gramicidin Revenue by Dosage Form (2017-2028)
8.2 Asia Pacific Gramicidin Market Size by Application
8.2.1 Asia Pacific Gramicidin Sales by Application (2017-2028)
8.2.2 Asia Pacific Gramicidin Revenue by Application (2017-2028)
8.3 Asia Pacific Gramicidin Market Size by Region
8.3.1 Asia Pacific Gramicidin Sales by Region (2017-2028)
8.3.2 Asia Pacific Gramicidin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Gramicidin Market Size by Dosage Form
9.1.1 Latin America Gramicidin Sales by Dosage Form (2017-2028)
9.1.2 Latin America Gramicidin Revenue by Dosage Form (2017-2028)
9.2 Latin America Gramicidin Market Size by Application
9.2.1 Latin America Gramicidin Sales by Application (2017-2028)
9.2.2 Latin America Gramicidin Revenue by Application (2017-2028)
9.3 Latin America Gramicidin Market Size by Country
9.3.1 Latin America Gramicidin Sales by Country (2017-2028)
9.3.2 Latin America Gramicidin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gramicidin Market Size by Dosage Form
10.1.1 Middle East and Africa Gramicidin Sales by Dosage Form (2017-2028)
10.1.2 Middle East and Africa Gramicidin Revenue by Dosage Form (2017-2028)
10.2 Middle East and Africa Gramicidin Market Size by Application
10.2.1 Middle East and Africa Gramicidin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Gramicidin Revenue by Application (2017-2028)
10.3 Middle East and Africa Gramicidin Market Size by Country
10.3.1 Middle East and Africa Gramicidin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Gramicidin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AbbVie Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbbVie Recent Developments
11.4 Amring Pharma
11.4.1 Amring Pharma Corporation Information
11.4.2 Amring Pharma Overview
11.4.3 Amring Pharma Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Amring Pharma Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amring Pharma Recent Developments
11.5 Bausch and Lomb
11.5.1 Bausch and Lomb Corporation Information
11.5.2 Bausch and Lomb Overview
11.5.3 Bausch and Lomb Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bausch and Lomb Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bausch and Lomb Recent Developments
11.6 Bimeda
11.6.1 Bimeda Corporation Information
11.6.2 Bimeda Overview
11.6.3 Bimeda Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bimeda Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bimeda Recent Developments
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Corporation Information
11.7.2 Bristol Myers Squibb Overview
11.7.3 Bristol Myers Squibb Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bristol Myers Squibb Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bristol Myers Squibb Recent Developments
11.8 Dow Pharma
11.8.1 Dow Pharma Corporation Information
11.8.2 Dow Pharma Overview
11.8.3 Dow Pharma Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dow Pharma Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dow Pharma Recent Developments
11.9 ERFA Canada
11.9.1 ERFA Canada Corporation Information
11.9.2 ERFA Canada Overview
11.9.3 ERFA Canada Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ERFA Canada Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ERFA Canada Recent Developments
11.10 Euro Pharm
11.10.1 Euro Pharm Corporation Information
11.10.2 Euro Pharm Overview
11.10.3 Euro Pharm Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Euro Pharm Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Euro Pharm Recent Developments
11.11 IPharma
11.11.1 IPharma Corporation Information
11.11.2 IPharma Overview
11.11.3 IPharma Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 IPharma Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 IPharma Recent Developments
11.12 Johnson and Johnson
11.12.1 Johnson and Johnson Corporation Information
11.12.2 Johnson and Johnson Overview
11.12.3 Johnson and Johnson Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Johnson and Johnson Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Johnson and Johnson Recent Developments
11.13 Odan Laboratories
11.13.1 Odan Laboratories Corporation Information
11.13.2 Odan Laboratories Overview
11.13.3 Odan Laboratories Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Odan Laboratories Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Odan Laboratories Recent Developments
11.14 Pfizer
11.14.1 Pfizer Corporation Information
11.14.2 Pfizer Overview
11.14.3 Pfizer Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pfizer Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pfizer Recent Developments
11.15 Sifi
11.15.1 Sifi Corporation Information
11.15.2 Sifi Overview
11.15.3 Sifi Gramicidin Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sifi Gramicidin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sifi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Gramicidin Industry Chain Analysis
12.2 Gramicidin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Gramicidin Production Mode & Process
12.4 Gramicidin Sales and Marketing
12.4.1 Gramicidin Sales Channels
12.4.2 Gramicidin Distributors
12.5 Gramicidin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Gramicidin Industry Trends
13.2 Gramicidin Market Drivers
13.3 Gramicidin Market Challenges
13.4 Gramicidin Market Restraints
14 Key Findings in The Global Gramicidin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer